Skip to main content
main-content

15.01.2019 | Original Article | Ausgabe 3/2019

Virchows Archiv 3/2019

Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)

Zeitschrift:
Virchows Archiv > Ausgabe 3/2019
Autoren:
Christopher Pool, Vonn Walter, Darrin Bann, David Goldenberg, James Broach, Max Hennessy, Elizabeth Cottrill, Erik Washburn, Nicole Williams, Henry Crist, Yuka Imamura, Joshua I. Warrick
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00428-018-02512-6) contains supplementary material, which is available to authorized users.
Christopher Pool and Vonn Walter are co-first authors

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

“Follicular variant” papillary thyroid carcinomas (FV-PTC) that do not histologically invade have a miniscule risk of metastasis, and thus been reclassified as a tumor of low malignant potential, the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). There are few molecular studies of this tumor type. We performed gene expression analysis, by RNA sequencing, on a series of FV-PTCs, NIFTPs, and follicular adenomas. A training set comprised tumors from The Cancer Genome Atlas (TCGA) repository (n = 46), digital slides from which were reviewed and classified as invasive or non-invasive FV-PTC. A validation set comprised in-house NIFTPs, invasive FV-PTCs, and follicular adenomas (n = 26). In the training set, unsupervised clustering separated tumors into three distinct expression subtypes, which associated with invasion and characteristic molecular alterations. Specifically, the “BRAF-like” subtype was enriched in invasive FV-PTCs and tumors with BRAF V600E mutations. The “THADA-like” subtype was enriched in non-invasive tumors and those with rearrangements involving THADA. The “RAS-family-like” subtype included many invasive and non-invasive FV-PTCs and was enriched in tumors with mutations in RAS family genes. In the validation set, nearest centroid analysis classified all invasive FV-PTCs as “BRAF-like” and all follicular adenomas as either “RAS-like” or “THADA-like.” NIFTPs were the most molecularly diverse histologic type, with cases classified as “BRAF-like,” “THADA-like,” and “RAS-family-like.” In conclusion, tumors fitting criteria for NIFTP are molecularly diverse, making it difficult to diagnose them with molecular studies, likely including matrial from cytopathology samples.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Zusatzmaterial
ESM 1 (PDF 562 kb)
428_2018_2512_MOESM1_ESM.pdf
ESM 2 (DOCX 21 kb)
428_2018_2512_MOESM2_ESM.docx
ESM 3 (DOCX 14 kb)
428_2018_2512_MOESM3_ESM.docx
ESM 4 (XLSX 4998 kb)
428_2018_2512_MOESM4_ESM.xlsx
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2019

Virchows Archiv 3/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie

01.08.2019 | Originalien | Ausgabe 4/2019

Cocainkonsumintensität als Ursache erworbener Herzerkrankungen?

Korrelationen bei cocainassoziierten Drogentodesfällen

26.06.2019 | Nebennierentumoren | CME | Ausgabe 4/2019

CME: Aktualisierter Überblick zu Tumoren der Nebenniere

Aktualisierter Überblick

26.06.2019 | Schwerpunkt: Sarkome | Ausgabe 4/2019

Diagnostik und Management von Gefäßmalformationen

Interdisziplinäres Teamwork gefragt

26.06.2019 | Schwerpunkt: Sarkome | Ausgabe 4/2019

Systemische Therapie von Sarkomen

Neue Biomarker und Therapiestrategien